165 related articles for article (PubMed ID: 16507780)
41. Expression of the AID protein in normal and neoplastic B cells.
Pasqualucci L; Guglielmino R; Houldsworth J; Mohr J; Aoufouchi S; Polakiewicz R; Chaganti RS; Dalla-Favera R
Blood; 2004 Nov; 104(10):3318-25. PubMed ID: 15304391
[TBL] [Abstract][Full Text] [Related]
42. Reclassification of 300 primary cutaneous B-Cell lymphomas according to the new WHO-EORTC classification for cutaneous lymphomas: comparison with previous classifications and identification of prognostic markers.
Senff NJ; Hoefnagel JJ; Jansen PM; Vermeer MH; van Baarlen J; Blokx WA; Canninga-van Dijk MR; Geerts ML; Hebeda KM; Kluin PM; Lam KH; Meijer CJ; Willemze R
J Clin Oncol; 2007 Apr; 25(12):1581-7. PubMed ID: 17353548
[TBL] [Abstract][Full Text] [Related]
43. Primary cutaneous follicle center lymphoma in a 16-year-old girl.
Edmonds N; Hernández-Pérez M; Holsinger M; Gru AA
J Cutan Pathol; 2021 May; 48(5):663-668. PubMed ID: 33326136
[TBL] [Abstract][Full Text] [Related]
44. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities.
Mottok A; Renné C; Seifert M; Oppermann E; Bechstein W; Hansmann ML; Küppers R; Bräuninger A
Blood; 2009 Nov; 114(20):4503-6. PubMed ID: 19734449
[TBL] [Abstract][Full Text] [Related]
45. Aberrant somatic hypermutation in transformation of follicular lymphoma and chronic lymphocytic leukemia to diffuse large B-cell lymphoma.
Rossi D; Berra E; Cerri M; Deambrogi C; Barbieri C; Franceschetti S; Lunghi M; Conconi A; Paulli M; Matolcsy A; Pasqualucci L; Capello D; Gaidano G
Haematologica; 2006 Oct; 91(10):1405-9. PubMed ID: 17018394
[TBL] [Abstract][Full Text] [Related]
46. Results of radiotherapy in 153 primary cutaneous B-Cell lymphomas classified according to the WHO-EORTC classification.
Senff NJ; Hoefnagel JJ; Neelis KJ; Vermeer MH; Noordijk EM; Willemze R;
Arch Dermatol; 2007 Dec; 143(12):1520-6. PubMed ID: 18087001
[TBL] [Abstract][Full Text] [Related]
47. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
[TBL] [Abstract][Full Text] [Related]
48. Analysis of aberrant somatic hypermutation (SHM) in non-Hodgkin's lymphomas of patients with chronic HCV infection.
Libra M; Capello D; Gloghini A; Laura P; Berra E; Cerri M; Gasparotto D; Franca S; De Re V; Gaidano G; Carbone A
J Pathol; 2005 May; 206(1):87-91. PubMed ID: 15809970
[TBL] [Abstract][Full Text] [Related]
49. Rheumatoid arthritis/methotrexate-associated primary cutaneous diffuse large B-cell lymphoma, leg type.
Matsumoto Y; Horiike S; Maekawa S; Isohisa T; Sakamoto N; Chinen Y; Nakayama R; Kiyota M; Nagoshi H; Mizutani S; Shimura Y; Sugitani M; Kobayashi T; Nakai N; Kuroda J; Taniwaki M
Intern Med; 2014; 53(11):1177-81. PubMed ID: 24881744
[TBL] [Abstract][Full Text] [Related]
50. An Aggressive Primary Cutaneous Follicle Center Lymphoma With c-MYC Translocation and CDKN2A (9p21) Deletion: A Case Report and Review of the Literature.
Tsang HC; Mathew S; Magro CM
Am J Dermatopathol; 2017 Mar; 39(3):e44-e49. PubMed ID: 27759694
[TBL] [Abstract][Full Text] [Related]
51. Presence of somatic hypermutation and activation-induced cytidine deaminase in acute lymphoblastic leukemia L2 with t(14;18)(q32;q21).
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Suzuki A; Saigo K; Kawano S; Takenokuchi M; Kumagai S; Matsuo Y; Koizumi T; Takeuchi M
Eur J Haematol; 2005 Jan; 74(1):11-9. PubMed ID: 15613101
[TBL] [Abstract][Full Text] [Related]
52. The value of molecular diagnostics in primary cutaneous B-cell lymphomas in the context of clinical findings, histology, and immunohistochemistry.
Felcht M; Booken N; Stroebel P; Goerdt S; Klemke CD
J Am Acad Dermatol; 2011 Jan; 64(1):135-43, 143.e1-4. PubMed ID: 21167409
[TBL] [Abstract][Full Text] [Related]
53. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study.
Grange F; Bekkenk MW; Wechsler J; Meijer CJ; Cerroni L; Bernengo M; Bosq J; Hedelin G; Fink Puches R; van Vloten WA; Joly P; Bagot M; Willemze R
J Clin Oncol; 2001 Aug; 19(16):3602-10. PubMed ID: 11504742
[TBL] [Abstract][Full Text] [Related]
54. Activation-induced cytidine deaminase expression in follicular lymphoma: association between AID expression and ongoing mutation in FL.
Hardianti MS; Tatsumi E; Syampurnawati M; Furuta K; Saigo K; Nakamachi Y; Kumagai S; Ohno H; Tanabe S; Uchida M; Yasuda N
Leukemia; 2004 Apr; 18(4):826-31. PubMed ID: 14990977
[TBL] [Abstract][Full Text] [Related]
55. Abnormal AP-1 protein expression in primary cutaneous B-cell lymphomas.
Mao X; Orchard G
Br J Dermatol; 2008 Jul; 159(1):145-51. PubMed ID: 18460027
[TBL] [Abstract][Full Text] [Related]
56. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
57. The histomorphologic spectrum of primary cutaneous diffuse large B-cell lymphoma: a study of 79 cases.
Plaza JA; Kacerovska D; Stockman DL; Buonaccorsi JN; Baillargeon P; Suster S; Kazakov DV
Am J Dermatopathol; 2011 Oct; 33(7):649-55; quiz 656-8. PubMed ID: 21937906
[TBL] [Abstract][Full Text] [Related]
58. Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression.
Gagyi E; Balogh Z; Bödör C; Timár B; Reiniger L; Deák L; Csomor J; Csernus B; Szepesi A; Matolcsy A
Haematologica; 2008 Dec; 93(12):1822-8. PubMed ID: 18945749
[TBL] [Abstract][Full Text] [Related]
59. AID is required for germinal center-derived lymphomagenesis.
Pasqualucci L; Bhagat G; Jankovic M; Compagno M; Smith P; Muramatsu M; Honjo T; Morse HC; Nussenzweig MC; Dalla-Favera R
Nat Genet; 2008 Jan; 40(1):108-12. PubMed ID: 18066064
[TBL] [Abstract][Full Text] [Related]
60. Programmed death-1 expression in cutaneous B-cell lymphoma.
Çetinözman F; Koens L; Jansen PM; Willemze R
J Cutan Pathol; 2014 Jan; 41(1):14-21. PubMed ID: 24151955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
